Eli Lilly & Co. has demonstrated a significant recovery, with its Zepbound injection pen gaining attention in the market. This stands in contrast to the struggles faced by large-cap stocks, which have underperformed in recent trading sessions.

Meanwhile, consumer staples stocks are on the rise in the broader market, indicating a shift in investor sentiment towards more stable sectors amidst economic uncertainties. This trend highlights the ongoing dynamics within the stock market as investors navigate varying performance across different sectors.

The CNBC Investing Club, led by Jim Cramer, continues to offer valuable insights for traders, particularly during the crucial last hour of trading on Wall Street. As market conditions evolve, the focus remains on how major companies like Eli Lilly adapt and respond to changing investor preferences.